New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19

被引：50

作者：

Aleissa, Muneerah M. ^{[1
]}

Silverman, Emily A. ^{[2
,3
]}

Acosta, Luisa M. Paredes ^{[4
,5
]}

Nutt, Cameron T. ^{[4
,5
]}

Richterman, Aaron ^{[6
]}

Marty, Francisco M. ^{[2
,3
,4
,5
]}

机构：

[1] Brigham & Womens Hosp, Dept Pharm, 75 Francis St, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA

[5] Harvard Med Sch, Boston, MA 02115 USA

[6] Hosp Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2021年 / 65卷 / 01期

关键词：

remdesivir; antiviral; COVID-19; SARS-CoV-2; EBOLA-VIRUS; CORONAVIRUS; GS-5734; MODEL;

D O I：

10.1128/AAC.01814-20

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Remdesivir was recently approved by the Food and Drug Administration for the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19). Remdesivir is the prodrug of an adenosine analogue that inhibits viral replication of several RNA virus families, including Coronaviridae. Preclinical data in animal models of coronavirus diseases, including COVID-19, have demonstrated that early treatment with remdesivir leads to improved survival, decreased lung injury, and decreased levels of viral RNA. Recent clinical data have demonstrated the clinical activity of remdesivir in terms of faster time to recovery in patients with severe COVID-19 and higher odds of improved clinical status in patients with moderate COVID-19. Here, clinical trials published to date are presented and appraised. Remdesivir's potential benefits and its favorable adverse-event profile make it an option for the treatment of COVID-19. This article examines the available literature describing remdesivir's pharmacology, pharmacokinetics, and preclinical and clinical data.

引用

页数：18

共 59 条

[1] Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19 [J].

Adamsick, Meagan L. ;

Gandhi, Ronak G. ;

Bidell, Monique R. ;

Elshaboury, Ramy H. ;

Bhattacharyya, Roby P. ;

Kim, Arthur Y. ;

Nigwekar, Sagar ;

Rhee, Eugene P. ;

Sise, Meghan E. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (07) :1384-1386

[2] Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].

Agostini, Maria L. ;

Andres, Erica L. ;

Sims, Amy C. ;

Graham, Rachel L. ;

Sheahan, Timothy P. ;

Lu, Xiaotao ;

Smith, Everett Clinton ;

Case, James Brett ;

Feng, Joy Y. ;

Jordan, Robert ;

Ray, Adrian S. ;

Cihlar, Tomas ;

Siegel, Dustin ;

Mackman, Richard L. ;

Clarke, Michael O. ;

Baric, Ralph S. ;

Denison, Mark R. .

MBIO, 2018, 9 (02)

[3]

[Anonymous], 2020, ROB 2 REVISED COCHRA

[4]

[Anonymous], 2020, ROLLING UPDATES CORO, P2020, DOI DOI 10.1101/2020.10.15.20209817

[5] Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient [J].

Baang, Ji Hoon ;

Smith, Christopher ;

Mirabelli, Carmen ;

Valesano, Andrew L. ;

Manthei, David M. ;

Bachman, Michael A. ;

Wobus, Christiane E. ;

Adams, Michael ;

Washer, Laraine ;

Martin, Emily T. ;

Lauring, Adam S. .

JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01) :23-27

[6] Remdesivir for the Treatment of Covid-19-Final Report [J].

Beigel, John H. ;

Tomashek, Kay M. ;

Dodd, Lori E. ;

Mehta, Aneesh K. ;

Zingman, Barry S. ;

Kalil, Andre C. ;

Hohmann, Elizabeth ;

Chu, Helen Y. ;

Luetkemeyer, Annie ;

Kline, Susan ;

de Castilla, Diego Lopez ;

Finberg, Robert W. ;

Dierberg, Kerry ;

Tapson, Victor ;

Hsieh, Lanny ;

Patterson, Thomas F. ;

Paredes, Roger ;

Sweeney, Daniel A. ;

Short, William R. ;

Touloumi, Giota ;

Lye, David Chien ;

Ohmagari, Norio ;

Oh, Myoung-don ;

Ruiz-Palacios, Guillermo M. ;

Benfield, Thomas ;

Faetkenheuer, Gerd ;

Kortepeter, Mark G. ;

Atmar, Robert L. ;

Creech, C. Buddy ;

Lundgren, Jens ;

Babiker, Abdel G. ;

Pett, Sarah ;

Neaton, James D. ;

Burgess, Timothy H. ;

Bonnett, Tyler ;

Green, Michelle ;

Makowski, Mat ;

Osinusi, Anu ;

Nayak, Seema ;

Lane, H. Clifford .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) :1813-1826

[7] Correlation Between Mutation Rate and Genome Size in Riboviruses: Mutation Rate of Bacteriophage Qβ [J].

Bradwell, Katie ;

Combe, Marine ;

Domingo-Calap, Pilar ;

Sanjuan, Rafael .

GENETICS, 2013, 195 (01) :243-251

[8] Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2 [J].

Chiotos, Kathleen ;

Hayes, Molly ;

Kimberlin, David W. ;

Jones, Sarah B. ;

James, Scott H. ;

Pinninti, Swetha G. ;

Yarbrough, April ;

Abzug, Mark J. ;

MacBrayne, Christine E. ;

Soma, Vijaya L. ;

Dulek, Daniel E. ;

Vora, Surabhi B. ;

Waghmare, Alpana ;

Wolf, Joshua ;

Olivero, Rosemary ;

Grapentine, Steven ;

Wattier, Rachel L. ;

Bio, Laura ;

Cross, Shane J. ;

Dillman, Nicholas O. ;

Downes, Kevin J. ;

Timberlake, Kathryn ;

Young, Jennifer ;

Orscheln, Rachel C. ;

Tamma, Pranita D. ;

Schwenk, Hayden T. ;

Zachariah, Philip ;

Aldrich, Margaret ;

Goldman, David L. ;

Groves, Helen E. ;

Lamb, Gabriella S. ;

Tribble, Alison C. ;

Hersh, Adam L. ;

Thorell, Emily A. ;

Denison, Mark R. ;

Ratner, Adam J. ;

Newland, Jason G. ;

Nakamura, Mari M. .

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (06) :701-715

[9] Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial [J].

Davey, Richard T., Jr. ;

Fernandez-Cruz, Eduardo ;

Markowitz, Norman ;

Pett, Sarah ;

Babiker, Abdel G. ;

Wentworth, Deborah ;

Khurana, Surender ;

Engen, Nicole ;

Gordin, Fred ;

Jain, Mamta K. ;

Kan, Virginia ;

Polizzotto, Mark N. ;

Riska, Paul ;

Ruxrungtham, Kiat ;

Temesgen, Zelalem ;

Lundgren, Jens ;

Beigel, John H. ;

Lane, H. Clifford ;

Neaton, James D. .

LANCET RESPIRATORY MEDICINE, 2019, 7 (11) :951-963

[10] Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection [J].

de Wit, Emmie ;

Feldmann, Friederike ;

Cronin, Jacqueline ;

Jordan, Robert ;

Okumura, Atsushi ;

Thomas, Tina ;

Scott, Dana ;

Cihlar, Tomas ;

Feldmann, Heinz .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (12) :6771-6776

← 1 2 3 4 5 6 →